ERBB2 and neoplasm: To investigate whether the different tissue penetration capacities result in different efficacies in tumor elimination in vivo, we established subcutaneous HER2+/CD44+ JIMT-1.ffLuc xenografts in NSG mice (Figure S1 and Figure 4a–c).